Targeting the transcription factors that drive certain cancers could lead to more effective, less toxic treatments.
Tag: leukemia
Michael E. Williams, MD, is a hematology/oncology researcher at UVA Health, exploring ways to reduce chemotherapy use in blood cancer.
Targeting fusion proteins may provide an improved therapeutic approach for leukemia patients.
Thomas Loughran, MD, reveals the most intriguing clinical applications for his LGL and acute myeloid leukemias research.
The Bone Marrow and Stem Cell Transplant Program at UVA Cancer Center has been designated as a National Marrow Donor Program (NMDP)/Be the Match® transplant center.